Evans Syndrome
📧 Sign up to get email alerts when something new happens for Evans Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 study to assess tolerability of ianalumab (VAY736) with investigator's choice thrombopoietin receptor agonist in patients with prima…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases [EARLY_Phase 1]
This entry describes an early-phase UCAR-T trial targeting CD19/BCMA for autoimmune hematologic diseases and notes that recruitment is ongoi…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia [Phase 1, Phase 2]
Clinical trial update for CM336 in relapsed or refractory autoimmune cytopenia, including immune thrombocytopenia, autoimmune hemolytic anem…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Severe Immune Cytopenia Registry Www.Sic-reg.Org
This entry provides a completed update on the Severe Immune Cytopenia Registry (SIC-reg), sponsored by the Medical University of Graz, cover…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies [Phase 2]
Phase 2 clinical trial update describing avatrombopag for adults with immune thrombocytopenia with autoantibodies, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Anti-CD38 Antibody Treating Evans Syndrome [Phase 2]
A Phase 2 clinical trial in China is evaluating an anti-CD38 antibody for Evans syndrome, with patient recruitment ongoing.
-
CLINICAL_TRIALS research · 2017-12-06Clinical Trial Update: Sirolimus for Autoimmune Disease of Blood Cells [Phase 1, Phase 2]
A phase 1/2 trial evaluating sirolimus for autoimmune blood cell disorders, including autoimmune pancytopenia and ALPS; the study is complet…